# Galvanize Therapeutics funding rounds and investors

As of 14 Oct 2026, Galvanize Therapeutics has raised $100M across 1 verified round on record; latest: $100 million Series C led by Sofinnova Partners, announced 3 Sep 2025.

Galvanize Therapeutics designs pulsed electric field energy devices for surgical ablation of soft tissue, targeting healthcare providers and hospitals.

Website: https://galvanizetx.com  
Headquarters: Redwood City, CA  
Page: https://fireround.dev/companies/galvanizetx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-09-03 | Series C | $100 million | Sofinnova Partners | Ally Bridge Group, Apple Tree Partners, Elevage Medical Technologies, Fidelity Management & Research Company, Gilmartin Capital, Intuitive Surgical, Janus Henderson Investors, Longaeva Partners, Norwest, Perceptive Xontogeny Venture Fund, T. Rowe Price | [prnewswire.com](https://www.prnewswire.com/news-releases/galvanize-therapeutics-raises-100-million-in-oversubscribed-series-c-financing-to-transform-the-treatment-of-cancer-and-chronic-lung-disease-302544329.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.